MethazolAMIDE 50 mg Oral Tablet
RxNorm 197940
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 197940 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: methazolAMIDE 50 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Methazolamide 50 mg Oral Tablet
(Atom ID: 12324632)
PSNPrescribable
Prescribable Name (PSN):
MethazolAMIDE 50 mg Oral Tablet
(Atom ID: 12438178)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MethazolAMIDE 50 mg Oral Tablet
(Atom ID: 12429028)
PTPrescribable
Designated preferred name (PT):
Methazolamide 50 mg oral tablet
(Atom ID: 9251833)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely methazolamide 50 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10314701)
Patient Education
Methazolamide
Methazolamide is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision). Methazolamide is in a class of medications called carbonic anhydrase inhibitors. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.